Will a new leukemia drug from Novartis be a quantum leap for cancer drug prices?
Novartis | August 23, 2017
When doctors talk about a new leukemia drug from Novartis, they ooze enthusiasm, using words like breakthrough, revolutionary and a watershed moment. But when they think about how much the therapy is likely to cost, their tone turns alarmist.